Trials / Unknown
UnknownNCT03580109
Spa Therapy for Upper or Lower Limb Lymphoedema
Spa Therapy for Upper or Lower Limb Lymphoedema : a Randomized and Comparative Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- Sponsor
- Association Francaise pour la Recherche Thermale · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
THERMOEDEME is a comparative, controlled, randomized, multicenter and simple blinded (investigator) trial. The aim of this study is to evaluate effects of spa therapy in phlebology with a therapeutic education program in daily life of patients suffering lymphoedema.
Detailed description
Lymphoedema is a chronic disease related to an insufficiency of the lymphatic system, which most often affects the limbs. Secondary forms are the most common, particularly those following surgical and radiotherapy treatments for cancer, the most classic being the post-therapeutic large arm of breast cancer. The lymphoedema is a traditional phlebology indication in spa therapy. The spa therapy linked with therapeutic education could constitute a favorable environment for the treatment of lymphoedema. The primary endpoint is the comparison of the rate of patients improved from baseline to 6 months on LMS27 (upper limb lymphoedema) or LYMQOL-LEG (lower limb lymphoedema) (Improvement is defined as 7 points between baseline and 6-month follow-up).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Immediate spa treatment | Spa treatment linked education therapeutic in lymphoedema post breast cancer (whirlpool bath with automatic air and water massage cycles, massaging shower/individuals and groups educational sessions) |
| OTHER | Late spa treatment | Spa treatment linked education therapeutic in lymphoedema post breast cancer (whirlpool bath with automatic air and water massage cycles, massaging shower/individuals and groups educational sessions) |
Timeline
- Start date
- 2019-06-20
- Primary completion
- 2024-12-01
- Completion
- 2025-12-01
- First posted
- 2018-07-09
- Last updated
- 2024-03-06
Locations
13 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03580109. Inclusion in this directory is not an endorsement.